Lymphoma

Our growing grasp of how lymphomas develop at the molecular level has sharpened diagnosis and revealed several molecular targets for treatment. Meanwhile, regulators in the United States and Europe have approved new medications, and these approvals have shifted how several types of lymphoid cancer are treated as standard practice.

This volume brings together the latest developments in the biology, diagnosis, and treatment of lymphomas, written by a group of authors from around the world. It belongs to the Current Clinical Oncology series.

The book is intended for medical oncologists, hematologists, radiation oncologists, and any physician who cares for patients with lymphoid malignancies.